203 related articles for article (PubMed ID: 22090274)
1. Insulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian syndrome.
Lungu AO; Zadeh ES; Goodling A; Cochran E; Gorden P
J Clin Endocrinol Metab; 2012 Feb; 97(2):563-7. PubMed ID: 22090274
[TBL] [Abstract][Full Text] [Related]
2. Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin Resistance.
Huang-Doran I; Kinzer AB; Jimenez-Linan M; Thackray K; Harris J; Adams CL; de Kerdanet M; Stears A; O'Rahilly S; Savage DB; Gorden P; Brown RJ; Semple RK
J Clin Endocrinol Metab; 2021 Jul; 106(8):2367-2383. PubMed ID: 33901270
[TBL] [Abstract][Full Text] [Related]
3. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients.
Musso C; Cochran E; Javor E; Young J; Depaoli AM; Gorden P
Metabolism; 2005 Feb; 54(2):255-63. PubMed ID: 15690321
[TBL] [Abstract][Full Text] [Related]
4. Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy.
Park JY; Chong AY; Cochran EK; Kleiner DE; Haller MJ; Schatz DA; Gorden P
J Clin Endocrinol Metab; 2008 Jan; 93(1):26-31. PubMed ID: 17940115
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
[TBL] [Abstract][Full Text] [Related]
6. Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy.
Oral EA; Ruiz E; Andewelt A; Sebring N; Wagner AJ; Depaoli AM; Gorden P
J Clin Endocrinol Metab; 2002 Jul; 87(7):3110-7. PubMed ID: 12107209
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome.
Fulghesu AM; Manca R; Loi S; Fruzzetti F
Fertil Steril; 2015 Mar; 103(3):808-14. PubMed ID: 25637475
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
9. [Effect of rosiglitazone on insulin resistance and hyperandrogenism in polycystic ovary syndrome].
Zheng Z; Li M; Lin Y; Ma Y
Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):271-3. PubMed ID: 12133398
[TBL] [Abstract][Full Text] [Related]
10. Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance.
Patlolla S; Vaikkakara S; Sachan A; Venkatanarasu A; Bachimanchi B; Bitla A; Settipalli S; Pathiputturu S; Sugali RN; Chiri S
Gynecol Endocrinol; 2018 Mar; 34(3):238-242. PubMed ID: 29068242
[TBL] [Abstract][Full Text] [Related]
11. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.
Kolodziejczyk B; Duleba AJ; Spaczynski RZ; Pawelczyk L
Fertil Steril; 2000 Jun; 73(6):1149-54. PubMed ID: 10856473
[TBL] [Abstract][Full Text] [Related]
12. Bilateral Adrenal Hyperplasia as a Possible Mechanism for Hyperandrogenism in Women With Polycystic Ovary Syndrome.
Gourgari E; Lodish M; Keil M; Sinaii N; Turkbey E; Lyssikatos C; Nesterova M; de la Luz Sierra M; Xekouki P; Khurana D; Ten S; Dobs A; Stratakis CA
J Clin Endocrinol Metab; 2016 Sep; 101(9):3353-60. PubMed ID: 27336356
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
[TBL] [Abstract][Full Text] [Related]
14. Leptin-replacement therapy for lipodystrophy.
Oral EA; Simha V; Ruiz E; Andewelt A; Premkumar A; Snell P; Wagner AJ; DePaoli AM; Reitman ML; Taylor SI; Gorden P; Garg A
N Engl J Med; 2002 Feb; 346(8):570-8. PubMed ID: 11856796
[TBL] [Abstract][Full Text] [Related]
15. Leptin concentrations in the polycystic ovary syndrome.
Mantzoros CS; Dunaif A; Flier JS
J Clin Endocrinol Metab; 1997 Jun; 82(6):1687-91. PubMed ID: 9177364
[TBL] [Abstract][Full Text] [Related]
16. Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study.
Puurunen J; Piltonen T; Puukka K; Ruokonen A; Savolainen MJ; Bloigu R; Morin-Papunen L; Tapanainen JS
J Clin Endocrinol Metab; 2013 Dec; 98(12):4798-807. PubMed ID: 24152688
[TBL] [Abstract][Full Text] [Related]
17. What have we learned form monogenic forms of severe insulin resistance associated with PCOS/HAIRAN?
Vigouroux C
Ann Endocrinol (Paris); 2010 May; 71(3):222-4. PubMed ID: 20362964
[TBL] [Abstract][Full Text] [Related]
18. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS.
Shorakae S; Ranasinha S; Abell S; Lambert G; Lambert E; de Courten B; Teede H
Clin Endocrinol (Oxf); 2018 Nov; 89(5):628-633. PubMed ID: 29992612
[TBL] [Abstract][Full Text] [Related]
19. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
Moghetti P; Tosi F; Bonin C; Di Sarra D; Fiers T; Kaufman JM; Giagulli VA; Signori C; Zambotti F; Dall'Alda M; Spiazzi G; Zanolin ME; Bonora E
J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073
[TBL] [Abstract][Full Text] [Related]
20. Early metabolic derangements in daughters of women with polycystic ovary syndrome.
Sir-Petermann T; Maliqueo M; Codner E; Echiburú B; Crisosto N; Pérez V; Pérez-Bravo F; Cassorla F
J Clin Endocrinol Metab; 2007 Dec; 92(12):4637-42. PubMed ID: 17848407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]